Cited by 495Hepatocellular Carcinoma Treatment and PrognosisMedical Imaging Techniques and ApplicationsMRI in cancer diagnosis

The DOI matches its Crossref record; 171 of the 179 references it cites were found in a registry or an index.

Advances in the early diagnosis of hepatocellular carcinoma

Open access

Wang, Weiyi, Wei, Chao·2020·Genes & Diseases

DOI 10.1016/j.gendis.2020.01.014PMC PMC7452544

Open this paper in CoChat — free account Open PDF

Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent cancers globally. In contrast to the declining death rates observed for all other common cancers such as breast, lung, and prostate cancers, the death rates for HCC continue to increase by ~2-3% per year because HCC is frequently diagnosed late and there is no curative therapy for an advanced HCC. The early diagnosis of HCC is truly a big challenge. Over the past years, the early diagnosis of HCC has relied on surveillance with ultrasonography (US) and serological assessments of alpha-fetoprotein (AFP). However, the specificity and sensitivity of US/AFP is not satisfactory enough to detect early onset HCC. Recent technological advancements offer hope for early HCC diagnosis. Herein, we review the progress made in HCC diagnostics, with a focus on emerging imaging techniques and biomarkers for early disease diagnosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.gendis.2020.01.014

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Diagnostic value of alpha-fetoprotein-L3 and Golgi protein 73 in hepatocellular carcinomas with low AFP levels
Xu, W., Guo, B.-L., Han, Y.-G., Shi, L., & Ma, W. (2014) · Tumor Biology · doi:10.1007/s13277-014-2506-8 · Cited by 34
Retracted
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,135
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
AASLD guidelines for the treatment of hepatocellular carcinoma
Heimbach, J. K., Kulik, L., Finn, R. S., Sirlin, C. B., Abecassis, M. M., Roberts, L. R., Zhu, A. X., Murad, M. H., & Marrero, J. A. (2017) · Hepatology · doi:10.1002/hep.29086 · Cited by 4,107
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Omata, M., Cheng, A., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,219
Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis
Tzartzeva, K., Obi, J., Rich, N. E., Parikh, N. D., Marrero, J. A., Yopp, A., Waljee, A. K., & Singal, A. G. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.064 · Cited by 1,207
MicroRNA and cancer
Jansson, M., & Lund, A. H. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.09.006 · Cited by 1,150

Show all 179 references

Sorted by citations

Items 201–300 of 495

Lenvatinib-resistant liver cancer-derived HSP90α-containing extracellular vesicles enhance drug resistance via macrophage CXCL8 secretion
Xu, X., Zhang, Y., Zhao, C.-W., Wu, H., Zhang, M., Ma, Y., Yu, Y. W., Zheng, L., Gu, F., & Chen, Y. (2025) · Immunology Letters · doi:10.1016/j.imlet.2025.107122 · Cited by 4
Dynamic contrast-enhanced magnetic resonance imaging assessment of residual tumor angiogenesis after insufficient microwave ablation and donafenib adjuvant therapy
Ren, Z., Feng, G., Li, B., Zhang, C., & Du, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-55416-8 · Cited by 4
99m Tc-Labeled D-Type PTP as a Plectin-Targeting Single-Photon Emission Computed Tomography Probe for Hepatocellular Carcinoma Imaging
Gong, J., Zhu, M., Zhao, L., Wang, T., Qiao, W., Huang, Q., Xing, Y. T., & Zhao, J. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00492 · Cited by 4
Poly(Ethylene Glycol)‐Modified Catalase Blocking Reactive Oxygen Species for the Treatment of Hepatic Ischemia
Gao, S., Li, F., Wu, D., Ma, R., Li, Y., Zhang, Y., Han, Z., He, Q., Li, J., Liu, C., et al. (2025) · Macromolecular Rapid Communications · doi:10.1002/marc.202500367 · Cited by 4
A Novel Micro SPR Sensor with Multiple Sensing Areas for Joint Detection of Early Liver Cancer Markers
Ma, J., Zhang, X., Su, X. M., Chen, H., Yu, H., Wang, R., & Li, D. (2021) · International Conference on Solid-State Sensors, Actuators and Microsystems · doi:10.1109/transducers50396.2021.9495738 · Cited by 4
Suppression of hepatocellular carcinoma progression by long noncoding RNA apolipoprotein C1 pseudogene via the regulation of the microRNA-106b-PTEN axis
Qian, Y., Chen, H., Chen, L., Ge, C., Zhu, D., & Zhou, D. (2023) · Translational Cancer Research · doi:10.21037/tcr-23-2189 · Cited by 4
A pathologic scoring system for predicting postoperative prognosis in patients with ruptured hepatocellular carcinoma
Xia, F., Zhang, Q., Xia, G., Ndhlovu, E., Chen, X., Huang, Z., Zhang, B., & Zhu, P. (2024) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2024.01.139 · Cited by 4
Ferroptosis in hepatocellular carcinoma, from mechanism to effect
Jiang, S., Zhang, G., Ma, Y., Wu, D., Xie, D., Zhou, S., & Jiang, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1350011 · Cited by 4
Construction and validation of somatic mutation-derived long non-coding RNAs signatures of genomic instability to predict prognosis of hepatocellular carcinoma
Duan, B., Zhao, X.-K., Cui, Y., Liu, D., Wang, L., Zhou, L., & Zhang, X. (2024) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v16.i3.842 · Cited by 4
Untargeted metabolomics of blood plasma samples of patients with hepatocellular carcinoma
Böhmová, A., Mikoška, M., Syslová, K., Šindelářová, D., Hříbek, P., Urbánek, P., & Setnička, V. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116263 · Cited by 4
Application of a single-cell-RNA-based biological-inspired graph neural network in diagnosis of primary liver tumors
Zhang, D.-H., Chen, L., Hu, S., Huang, X., Yu, L., Meng, X., Guo, X.-J., Zeng, H., Chen, Z., Zhang, L., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05670-1 · Cited by 4
Diagnostic performance of microRNAs for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis
Huang, T., Chen, J., Zhang, P., Wang, R., Liu, Y., & Lu, C. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2024.1483196 · Cited by 4
Evaluating the combined diagnostic power of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II for hepatocellular carcinoma
Zhang, S., Gao, C., Wang, Y., Chen, L., & Gao, S. (2025) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-2024-863 · Cited by 4
Carbon nanomaterials-based electrochemical cancer biomarkers biosensors
Rodrı́guez, M. C., Dalmasso, P. R., Rubianes, M. D., Bollo, S., Gallay, P. A., Mujica, M. L., Montemerlo, A., Perrachione, F., Tamborelli, L. A., Vaschetti, V. M., et al. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822859-3.00020-1 · Cited by 4
Exosomal miRNA in early-stage hepatocellular carcinoma
Wu, Z., Zhu, Y.-X., Jin, Y., & Zhan, Y.-C. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i3.528 · Cited by 5
Sex Differences in the Impact of Metabolic Dysfunction-associated Fatty Liver Disease on the of Patients with Hepatocellular Carcinoma After Radical Resection
Huang, J., Wei, S.-S., Tang, Y.-T., Zhang, Q., Luo, H.-L., Tang, Z.-Y., Tang, Y., Liu, H., Huang, W., Dong, X.-F., et al. (2023) · Journal of Cancer · doi:10.7150/jca.83779 · Cited by 5
Upregulation of helicase-like transcription factor predicts poor prognosis and facilitates hepatocellular carcinoma progression
Cen, X., Lu, Y., Lü, J., Zhan, P., Cheng, Y., Luo, C., Liu, J., Xie, C., & Wang, F. (2023) · Human Cell · doi:10.1007/s13577-023-00917-3 · Cited by 4
Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis
Do, X.-H., Le, M. T., Nguyen, T. H., Le, T. T., Nguyen, X., Mai, T. B., Hoang, T. M. N., & Than, U. T. T. (2023) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s409649 · Cited by 4
CircUSP10 promotes liver cancer progression by regulating miR-211-5p/TCF12/EMT signaling pathway
Chen, X., Xu, Y., Zhou, Z., Zhao, P., Zhou, Z., Wang, F., Zhong, F., & Du, H. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20649 · Cited by 4
Current state of radiomics in hepatobiliary and pancreatic malignancies
Grewal, M., Ahmed, T. M., & Javed, A. A. (2023) · Artificial Intelligence Surgery · doi:10.20517/ais.2023.28 · Cited by 5
Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis
Xiang, X., Bhowmick, K., Shetty, K., Ohshiro, K., Yang, X., Wong, L. L., Yu, H., Latham, P. S., Satapathy, S. K., Brennan, C., et al. (2024) · Genes & Cancer · doi:10.18632/genesandcancer.234 · Cited by 4
The Biological Functions and Clinical Values of Exosomal Circular RNAs in Hepatocellular Carcinoma
Zhao, Y. Y., & Yao, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.885214 · Cited by 4
The Multifaceted Functionality of Plasmacytoid Dendritic Cells in Gastrointestinal Cancers: A Potential Therapeutic Target?
Hansen, F. J., David, P., & Weber, G. F. (2024) · Cancers · doi:10.3390/cancers16122216 · Cited by 4
The combination of serum lncRNA PTTG3P and mRNA PTTG1 serves as a diagnostic and prognostic marker for hepatocellular carcinoma
Cao, S., Zhong, F., Chen, X., Ke, S., Zhong, X., Li, T., Sha, Y.-H., Kang, C., Qin, S., Wang, H., et al. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13409 · Cited by 3
Epigenetic activation of JAG1 by AID contributes to metastasis of hepatocellular carcinoma
Jiao, J., Shao, K., Liu, Z., Liu, L., Nie, Z., Wu, J., Shi, X., Wang, R., Qian, Z., Yang, A., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108078 · Cited by 3
NEK6 Accelerates Hepatocellular Carcinoma Progression and Glycolysis through Ubiquitination of TCP10L
Su, L., Zhao, D., Zhou, C., & Zhang, B. (2025) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukaryotgeneexpr.2025057446 · Cited by 3
Preliminary Evaluation of Plasma circ_0009910, circ_0027478, and miR-1236-3p as Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma
Awed, M. S., Ibrahim, A. M. A., Ezzat, O., Fawzy, A., Sabir, D. K., & Radwan, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104842 · Cited by 3
Plasma metabolomic profiling for hepatocellular carcinoma diagnosis and microvascular invasion prediction
Huang, F., Jiang, H., Shen, M., Zhang, C., Chen, Y., Pan, B., Wang, B., Guo, W., & Yang, W. (2025) · International Journal of Cancer · doi:10.1002/ijc.70055 · Cited by 3
Targeting FUT1-mediated EGFR fucosylation and COX-2 reverses gemcitabine resistance by activating immunogenic cell death in hepatocellular carcinoma
Li, N., Hu, B., Liu, C., Du, K., Guo, B., Yan, M., Chu, S., Zeng, M., Sun, X., Wu, X., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109111 · Cited by 3
Automated predictive framework using AI and deep learning approaches for early detection and classification of liver cancer
Dai, Y., Gao, F., Chen, Y., Xu, S., Qiu, C., & Cai, X. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1650800 · Cited by 3
Inhibition of RBPJ transcription complex promotes IL-17 and IFN-γ secretion by CD4⁺ T cells in hepatocellular carcinoma
Yao, Y., Zhang, X., Wu, H., Pan, B., Zhang, Z., Ye, D., Wang, X., & Tang, N. (2025) · Archives of Pharmacal Research · doi:10.1007/s12272-025-01587-5 · Cited by 3
Lasiodin sensitizes hepatocellular carcinoma cancer to sorafenib via SNARE complex disruption
Lian, M., Zhang, Y., Huang, J., Wang, D., Cao, L., Li, X., Tang, D., Niu, N., Li, Y., Li, J., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157603 · Cited by 3
Explainable artificial intelligence and ensemble learning for hepatocellular carcinoma classification: State of the art, performance, and clinical implications
Akbulut, S., & Çolak, C. (2025) · World Journal of Hepatology · doi:10.4254/wjh.v17.i11.109494 · Cited by 3
Recombinant human type-5 adenovirus (H101) combined with radiofrequency ablation versus traditional radiofrequency ablation for hepatocellular carcinoma ≤3 cm: a phase III randomized controlled trial
Dai, H.-S., Liu, Z.-P., Bi, H., Tan, D.-H., Luo, Y.-L., Yin, X.-Y., Gong, Y., Ma, K., Chen, Z., & Feng, K. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000004438 · Cited by 3
PDP1 drives hepatocellular carcinoma progression by regulating senescence through the cAMP/Ca2+ signaling pathway
Xie, J., Pan, X., & Xia, Y. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117772 · Cited by 3
lncRNA EPS15-AS1 affects the biological behavior of liver cancer stem cells by regulating EPS15 expression.
Liu, G., Lan, Y., Yin, X., & Wu, T. (2022) · PubMed Central · Cited by 3
Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients
Liu, Y., Shen, B., Huang, T., Wang, J., & Jiang, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288013 · Cited by 3
Novel ProTide prodrugs of 5-fluoro-2′-deoxyuridine for the treatment of liver cancer
Jiang, L., Pan, T. S., Lv, Q., Yuan, W., Liu, X., Qu, X., Luo, D., Wan, S., & Cui, S. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115763 · Cited by 3
Integrated analysis and validation of the TRIM28-H2AX-CDK4 diagnostic model assists to predict the progression of HCC
Tian, Q., Lu, G., Ma, Y., Ma, L., Shang, Y., Guo, N., Huang, Y., Zhu, L., & Du, R. (2023) · Aging · doi:10.18632/aging.205137 · Cited by 3
CENPB promotes the proliferation of hepatocellular carcinoma and is directly regulated by miR-29a
Wang, X., Luo, L., Zhang, Y., Liu, G., Fang, Z., Xu, Z., & Hu, X. (2023) · Aging · doi:10.18632/aging.205171 · Cited by 3
CircUCK2 promotes hepatocellular carcinoma development by upregulating UCK2 in a mir-149-5p-dependent manner
Shen, M., Zhang, Q., Pan, W., & Wang, B. (2024) · Discover Oncology · doi:10.1007/s12672-024-00863-y · Cited by 3
PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma
Jin, W., Wang, G., Dong, M., & Wang, X. (2024) · European journal of medical research · doi:10.1186/s40001-024-01787-7 · Cited by 3
SLC1A4 Promotes Malignant Transformation of Hepatocellular Carcinoma by Activating the AKT Signaling
Zheng, J., & Gong, J. (2025) · Analytical Cellular Pathology · doi:10.1155/ancp/1115184 · Cited by 3
Programmed cell death protein 5 inhibits hepatocellular carcinoma progression by inducing pyroptosis through regulation of TGF-β/Smad2/3/Snail pathway
Wang, Y., Huang, S., Cai, Y., Wang, T., Zhao, H., Lin, X., Wang, X., & Li, P. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167696 · Cited by 3
Identification of methionine metabolism related prognostic model and tumor suppressive functions of BHMT in hepatocellular carcinoma
Liu, W., Hu, K., Fu, Y., Zhou, T., Zhong, Q., Wang, W., Gui, Y., Zhang, P., Yao, D., Yang, X., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-93650-w · Cited by 3
Self-citation
Progress in ubiquitination and hepatocellular carcinoma: a bibliometric analysis
Li, M., Xu, Z., Liang, S., Lv, Q., You, X., Yuan, T., He, J., & Tu, Q. (2025) · Discover Oncology · doi:10.1007/s12672-025-02155-5 · Cited by 3
Exploring the mechanism of Naringenin in the treatment of hepatocellular carcinoma based on mRNA sequencing and experimental validation
Zhang, Z., Wang, H., Liu, X., He, M., & Lin, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-09013-y · Cited by 3
Improving the antitumor efficiency against hepatocellular carcinoma by harmine-loaded liposomes with mitochondria targeting and legumain response
Hafiz, I., Li, Z., Wang, Z., He, H., Tang, X., & Wang, M. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103623 · Cited by 3
Screening of Hub Genes in Hepatocellular Carcinoma Based on Network Analysis and Machine Learning
Zhang, Y., Xie, Y., Huang, X., Zhang, L., & Shu, K. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/7300788 · Cited by 3
DTL is a Novel Downstream Gene of E2F1 that Promotes the Progression of Hepatocellular Carcinoma
Dong, R., Zhang, D., Han, B., Xu, L., Zhang, D., Cheng, Z., & Qiu, X. (2023) · Current Cancer Drug Targets · doi:10.2174/1568009623666230511100246 · Cited by 3
Combined Serum CXCL8, CXCL9 And CXCL13 Tests for the Prediction of Microvascular Invasion in Hepatocellular Carcinoma
Liu, H., Bai, Y., Li, F., & Tian, Z. (2023) · Biomarkers in Medicine · doi:10.2217/bmm-2023-0064 · Cited by 3
The Potential Role of Circulating Long Miscellaneous RNAs in the Diagnosis and Prognosis of Hepatitis C Related Hepatocellular Carcinoma
Abdelsattar, S., Fahim, S. A., Kamel, H. F. M., Al-Amodi, H. S. A. B., Kasemy, Z. A. A., Khalil, F. O., Abdallah, M. S., Bedair, H. M., Gadallah, A.-N. A.-A., Sabry, A., et al. (2023) · Non-Coding RNA · doi:10.3390/ncrna9050062 · Cited by 3
CircularRNA Hsa_circ_0093335 promotes hepatocellular carcinoma progression via sponging miR‐338‐5p
Qin, X., Lingyu, Z., Shen, Y., Gu, Y., Tang, J., Qian, J., Cui, A., & Chen, M. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17991 · Cited by 3
Construction of a hepatocellular carcinoma high-risk population rating scale and independent predictors' assessment
Li, M., Sun, J., Wang, Y., Ma, J., Hao, X., Liu, Y., Zhou, C., & Zhou, H. (2023) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2023.11.016 · Cited by 3
Paraneoplastic Cutaneous Manifestations of Hepatocellular Carcinoma. A Systematic Review and Meta-analysis
Al-Showbaki, L., Toubasi, A. A., Jaber, D. Z., Shdifat, M. A., Almaani, N., Alqudah, O., Al-Fararjeh, F., & Amir, E. (2024) · Journal of Cancer · doi:10.7150/jca.88931 · Cited by 3
Hu-Qi-Zheng-Xiao Decoction Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Suppressing the HIF-1α Signaling Pathway to Inhibit EMT, LCSC, and Angiogenic Process
Wang, X., Yin, L., Chai, M., Kou, B., Liu, X., & Wang, X. (2024) · Integrative Cancer Therapies · doi:10.1177/15347354231226126 · Cited by 3
Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers
Huang, C., Xiao, X., Lin, T., Gao, Z., Ji, J., Zhou, L., Li, Y., Liu, L., Feng, H., Fang, M., et al. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s447700 · Cited by 3
Hepatocellular Carcinoma Detection by Cell Sensor Based on Anti-GPC3 Single-Chain Variable Fragment
Yan, Z., Che, Z., Shi, Z., Lv, J., Yang, L., Lu, T., Lu, Y., Shan, J., & Liu, Q. (2024) · Advanced Devices & Instrumentation · doi:10.34133/adi.0043 · Cited by 3
Elevation of S2 ‐bound α1‐acid glycoprotein is associated with chronic hepatitis C virus infection and hepatocellular carcinoma
Oltmanns, C., Bremer, B., Kusche, L., Stal, P. I., Zenlander, R., Tauwaldt, J., Rydén, I., Påhlsson, P., Cornberg, M., & Wedemeyer, H. H. (2024) · Journal of Viral Hepatitis · doi:10.1111/jvh.13943 · Cited by 3
PVALB Was Identified as an Independent Prognostic Factor for HCC Closely Related to Immunity, and Its Absence Accelerates Tumor Progression by Regulating NK Cell Infiltration
Gong, Y., Zhou, M., Zhu, Y., Pan, J., Zhou, X., Jiang, Y., Zeng, H., Zheng, H., Geng, X., & Huang, D. (2024) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s450479 · Cited by 3
Combined Model for the Diagnosis of Hepatocellular Carcinoma: A Pilot Study Comparing the Liver to Spleen Volume Ratio and Liver Vein to Cava Attenuation
Abenavoli, L., Scarlata, G. G. M., Gambardella, M. L., Battaglia, C., Borelli, M., Manti, F., & Laganà, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124306 · Cited by 3
Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs
Du, F., Sun, H., Sun, F., Yang, S., Tan, H., Li, X., Chai, Y., Jiang, Q., & Han, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924523 · Cited by 3
The Application of Image Processing in Liver Cancer Detection
Sharma, M., & Parveen, R. (2021) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2021.0121050 · Cited by 3
Active compounds and potential targets of Shuganning injection in the treatment of hepatocellular carcinoma by network pharmacology and in vitro validation
Han, X., Huang, J., Lu, J., He, F., Wang, F., Li, S., Zhong, H., Yu, H., & Pu, W. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02432-6 · Cited by 2
UTP11 promotes the growth of hepatocellular carcinoma by enhancing the mRNA stability of Oct4
Chen, Y., Zhang, X., Zhang, M., Fan, W., Lin, Y., & Li, G. (2024) · BMC Cancer · doi:10.1186/s12885-023-11794-2 · Cited by 2
Interaction between coagulation and inflammatory system in liver disease: re-focus on hematological markers
Lu, L., Zhu, C., Zhou, D., Li, S., Yi, L., Wei, S., & Peng, Q. (2024) · Biomarkers in Medicine · doi:10.1080/17520363.2024.2395245 · Cited by 2
Global research trends and frontiers in ferroptosis in hepatocellular carcinoma: a bibliometric and visualization study
Ning, L., Chen, D., Han, J., Xie, G., & Sun, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1474496 · Cited by 2
The Role of Stereotactic Body Radiation Therapy in the Outcomes of Intrahepatic Recurrent Small Hepatocellular Carcinoma
Shui, Y., Dai, D., Yang, Y., Yang, J., Feng, X., Chen, H., Liu, L., Yu, Q., Guo, Y., Yu, R., et al. (2025) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2025.102561 · Cited by 2
A novel in-depth “static- dynamic” lipidomics workflow to reveal lipids reprogramming in hepatocellular carcinoma
Yan, J., Zhang, Y., Zheng, X.-X., Tang, Z., Guo, W., Li, S., Li, J., Xu, H., Li, Q., & Zhang, Q. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116880 · Cited by 2
RNF157 targets RIG-I/DDX58 to promote proliferation in liver cancer
Ma, C., Yang, Q., Yu, G., Li, A., Tu, C., Wang, J., Zhang, W., Chen, L., Teng, D., Wang, Q., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14224-7 · Cited by 2
Downregulation of MPC1 promotes HCC cell proliferation and metastasis via the STAT3 pathway
Shan, D., Zheng, Q., & Chen, Z. J. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10435-1 · Cited by 2
Development and Evaluation of a Droplet Digital PCR Assay for the Accurately Detecting the CircHIPK3 in Plasma Samples from Patients with Hepatocellular Carcinoma
Ji, Y., Tuo, P., Zhang, S., Cai, T., Fu, L., Deng, Q., Fu, H., Gao, G., Wang, F., & Zhu, P. X. (2025) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2412.12048 · Cited by 2
Identification of M0 macrophage associated lipid metabolism genes for prognostic and immunotherapeutic response prediction in hepatocellular carcinoma
Zhou, H., Ming, L., Liang, Z., Zhao, H., Wang, Y., Huang, Q., & Ou, C. (2025) · Discover Oncology · doi:10.1007/s12672-025-02620-1 · Cited by 2
Pragmatic Approach to Hepatocellular Carcinoma Diagnosis in High-Incidence, Resource-Limited Settings in Africa
Kirk, G. D., Nsibirwa, S. K., Aizire, J., Assefa, R. L., Bandala-Jacques, A., Orem, J., Maponga, T. G., Seydi, M., Wandeler, G., Mohareb, A. M., et al. (2025) · JCO Global Oncology · doi:10.1200/go-24-00592 · Cited by 2
Prognostic and immunotherapeutic significance of NCAPD2 in pan-cancer and its role in hepatocellular carcinoma progression via the AKT/GSK-3β signaling pathway
Ma, W., Tian, Y., Shen, W., Song, Z., Yang, B. Y., Zhou, D., & Ye, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-96654-8 · Cited by 2
The SMIM25-COX-2 Axis Modulates the Immunosuppressive Tumor Microenvironment and Predicts Immunotherapy Response in Hepatocellular Carcinoma
Wang, Z., Li, X., Zhang, S., Sun, J., Lu, Q., Tao, Y., Liang, S., Lan, X., Zhong, J., & Wang, Q. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090693 · Cited by 2
A Low‐Molecular‐Weight Polysaccharide From Cremastra Appendiculata : Extraction, Structural Characterization, and Anti‐HCC Activity
Kong, H., Li, W., Wang, Y., Wang, Y., Jiang, G., Wang, J., & Niu, J. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500376 · Cited by 2
Therapeutic Potential of Nanoscale Metal–Organic Frameworks in Hepatocellular Carcinoma
Tutunchi, H., Nabipour, H., & Rohani, S. (2025) · Nanomaterials · doi:10.3390/nano15231771 · Cited by 2
Integrative Spatial Transcriptomics and Experimental Validation Reveal UBC-Mediated EMT Associated with Immune Evasion in Hepatocellular Carcinoma
Li, X., Qin, X., Shi, K., Lu, G., Tian, G., Chen, Y., & Yao, R. (2025) · ImmunoTargets and Therapy · doi:10.2147/itt.s567643 · Cited by 2
Novel Blood-Based Liquid Biopsy Approaches in Hepatocellular Carcinoma
Anand, N., Wu, S., Guo, Z., Figueroa, M. S., Jung, L., Li, M., Bhan, I., & Franses, J. W. (2025) · JCO oncology advances. · doi:10.1200/oa-25-00132 · Cited by 2
Injectable multi-component hydrogel as an inhibitor of choline kinase α achieved the treatment of malignant ascites by inhibiting PI3K/AKT/mTOR signaling pathway
Yang, Y., Qi, J., Zhu, Z., Wu, M., Zhao, Y., Wang, M., Lang, Y., Gu, Y., Liu, Y., & Cai, M. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.01.001 · Cited by 2
A systematic review of MicroRNA (miRNA) biomarkers in the diagnosis and prognosis of hepatocellular carcinoma
Britto, J. M. J., & Bell, T. B. (2026) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-04162-5 · Cited by 2
Validation of Protein Biomarker Candidates for Diagnosis of HBV induced HCC
Ahmed, A., AL‐Ansi, W., Basharat, S., Ye, L., & Bai, Z. (2022) · International Journal of Advances in Agricultural Science and Technology · doi:10.47856/ijaast.2022.v09i03.002 · Cited by 2
Feasibility of hepatocellular carcinoma treatment based on the tumor microenvironment
Wang, H., Shi, F., Zheng, S., Zhao, M., Pan, Z., Xiong, L., & Zheng, L. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.896662 · Cited by 2
NIO-1, A Novel Inhibitor of OCT1, Enhances the Antitumor Action of Radiofrequency Ablation against Hepatocellular Carcinoma
Yang, H., Yang, Y., Zou, X.-Z., Zhang, Q., Li, X., Zhang, C., Wang, Y., & Ren, X. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230526154739 · Cited by 2
A Flexible Broadband Visible Light Plasmon‐Absorber Based on a 2D Monolayer of Au‐Nanoparticle/TiO2‐Nanowire Core–Shell Heterostructures
Ko, W., Yeh, S., Hsu, Y., Chu, H., & Lin, K. (2023) · Advanced Materials Interfaces · doi:10.1002/admi.202300415 · Cited by 2
Association of elevated autoantibody to high expression of GNAS in hepatocellular carcinoma
Wang, K., Qiu, C., Xing, M., Li, M., Wang, B., Ye, H., Shi, J., Dai, L., Wang, X. D., & Wang, P. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22627 · Cited by 2
Cross talk between genetics and biochemistry in the pathogenesis of hepatocellular carcinoma
Üçdal, M. T., Burus, A., & Celtikci, B. (2024) · Hepatology forum/Hepatology forum (Online) · doi:10.14744/hf.2023.2023.0028 · Cited by 2
Analysis of m6A-related lncRNAs for prognostic and immunotherapeutic response in hepatocellular carcinoma
Wu, X., Wang, S., Wu, X., Chen, Q., Jin, C. S., & Qi, Z. (2024) · Journal of Cancer · doi:10.7150/jca.92128 · Cited by 2
Exploring the impact of insufficient thermal ablation on hepatocellular carcinoma: NDST2 overexpression mechanism and its role in facilitating growth and invasion of residual cancer cells
Wan, W., Guo, D., Tong, K., Pang, J., Pan, Y., Chen, J., Liao, W., Chen, Y., Lin, P., Li, L., et al. (2024) · International Journal of Hyperthermia · doi:10.1080/02656736.2024.2353309 · Cited by 2
Breaking Down the Arsenal: Recent Progress in the Nanotherapeutic Strategies for Hepatocellular Carcinoma Treatment
Roy, S., Harish, V., Mohd, S., & Singh, S. K. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400126 · Cited by 2
Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer
Tian, J., Pan, S., Wang, Y., Yu, Y., Wang, S., Shen, Y., Yang, L., Liu, X., Qiu, Q., Luan, J., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12122769 · Cited by 2
Application of Indirect ELISA and PCR Techniques for Detecting of Hepatocellular Carcinoma using Des-gamma Carboxyprothrombin, Alpha-fetoprotein, and Thioredoxin Biomarkers
Duong, H. Q., Khai, N. X., Thinh, T. H., Linh, B. T., Minh, N. N., & Vo, T. T. B. (2025) · Molecular Biotechnology · doi:10.1007/s12033-025-01401-z · Cited by 2
TTLL4 mediates the PI3K/AKT/MDM2 pathway to promote hepatocellular carcinoma progression and predict patient prognosis
He, Z., Chen, D., Li, L., Li, S., Song, F., Cai, J., Guo, X., Luo, Y., Wang, X., Chen, Z., et al. (2025) · APL Bioengineering · doi:10.1063/5.0267938 · Cited by 2
The role of mitochondria-related genes in hepatocellular carcinoma prognosis: construction of prognostic models based on machine learning
Gao, F., Teng, F., Wan, Y., Zhang, Q., & Huang, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-03216-5 · Cited by 2
Machine Learning-Based Liver Cancer Classification Using Gene Expression Microarray Data
Mahmoud, A., Meraj, S. S., Saini, S., Juneja, S., Talpur, K. R., Shah, A., & Ahmed, W. M. (2024) · IEEE International Conference on Engineering Technologies and Applied Sciences (ICETAS) · doi:10.1109/icetas62372.2024.11119847 · Cited by 2
Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing
Chen, W., Zhang, F., Xu, H., Hou, X., Tang, D., & Dai, Y. (2022) · Pathology & Oncology Research · doi:10.3389/pore.2022.1610199 · Cited by 2
A comprehensive review of the role of LINC00462 in human disorders
AmeliMojarad, M., & AmeliMojarad, M. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154370 · Cited by 2
Prognostic model of hepatocellular carcinoma based on cancer grade
Zhang, G., Ding, X., & Wang, Y. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i27.6383 · Cited by 2
Effect of coronavirus disease 2019 on diagnosis and treatment of hepatocellular carcinoma: a systematic review
Mazidimoradi, A., Birjandi, S. S., & Salehiniya, H. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00179 · Cited by 2

Authors: Wang, W., & Wei, C.
Corresponding author: Wei, Chao
ORCID: Wang, Weiyi
Wei, Chao
Venue: Genes & Diseases
Publisher: Elsevier BV
Published: 2020-09
Volume: 7
Issue: 3
Pages: 308-319
ISSN: 2352-3042 (ISSN-L)
DOI: 10.1016/j.gendis.2020.01.014
PMC: PMC7452544
OpenAlex: W3003360914
Cited by: 492
References: 179
Citations by year: 2026: 56 · 2025: 107 · 2024: 126 · 2023: 108 · 2022: 74 · 2021: 19 · 2020: 2
FWCI: 6.76
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc-nd
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Genes & Diseases (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics: Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
Keywords: hepatocellular carcinoma, early diagnosis, alpha-fetoprotein, ultrasonography, cancer surveillance, imaging modalities, biomarkers, sensitivity and specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Advances in the early diagnosis of hepatocellular carcinoma

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks